Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

CollPlant Biotechnologies (CLGN) Interest Expenses (2018 - 2023)

CollPlant Biotechnologies filings provide 6 years of Interest Expenses readings, the most recent being $196000.0 for Q1 2023.

  • On a quarterly basis, Interest Expenses rose 113.04% to $196000.0 in Q1 2023 year-over-year; TTM through Dec 2023 was $196000.0, a 113.04% increase, with the full-year FY2020 number at $34000.0, down 98.97% from a year prior.
  • Interest Expenses hit $196000.0 in Q1 2023 for CollPlant Biotechnologies, up from $92000.0 in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $8.0 million in Q4 2020 to a low of -$11.0 million in Q3 2020.
  • Median Interest Expenses over the past 5 years was -$6000.0 (2019), compared with a mean of -$618307.7.
  • Biggest five-year swings in Interest Expenses: crashed 23283.33% in 2019 and later surged 584.21% in 2022.
  • CollPlant Biotechnologies' Interest Expenses stood at $4.7 million in 2019, then skyrocketed by 72.7% to $8.0 million in 2020, then plummeted by 199.58% to -$8.0 million in 2021, then skyrocketed by 101.15% to $92000.0 in 2022, then surged by 113.04% to $196000.0 in 2023.
  • The last three reported values for Interest Expenses were $196000.0 (Q1 2023), $92000.0 (Q1 2022), and -$8.0 million (Q3 2021) per Business Quant data.